Europe Allergy Diagnostics Market Size, Share & Industry Trends Analysis Report by End-user, Allergen, Test Type, Product & Services, Country and Growth Forecast, 2022-2028

The Europe Allergy Diagnostics Market would witness market growth of 12.9% CAGR during the forecast period (2022-2028).

Allergies to insect stings can cause discomfort, edema, as well as redness at the sting site. Drug allergies can result from an allergic reaction to one or even more of a drug's constituents and can manifest as symptoms including skin rash, hives, irritated eyes, and facial swelling. Small fungal spores in the air are what cause mould allergies, which can produce symptoms including watery eyes, runny noses, itchy mouths, and sneezing.

Although allergies can manifest at any age, children under the age of five are particularly prone to allergy conditions. Allergy diagnostics is the process of identifying an allergic disease's characteristics and selecting how to treat it.

If an individual has allergies, his/her immune system might overreact to something that they touched or breathed in while engaging in an outdoor activity or even at home. They could have symptoms including itching, swelling, vomiting, breathing difficulties, hives, and other serious symptoms if they consume a peanut butter sandwich, have a carpet in the bedroom, or take aspirin.

Many nations are launching daring initiatives for healthcare reform and development in response to rising healthcare demand and the requirement to meet citizens' aspirations. These initiatives are creating new chances for close collaboration with the healthcare industries and institutions. Taking advantage of its extensive expertise in managing the largest integrated national health system in the world, the UK provides services that are exceptional in both quality and breadth.

The Germany market dominated the Europe Allergy Diagnostics Market by Country in 2021; thereby, achieving a market value of $752 million by 2028. The UK market would exhibit a CAGR of 11.9% during (2022-2028). Additionally, The France market is anticipated to grow at a CAGR of 13.7% during (2022-2028).

Based on End-user, the market is segmented into Diagnostic Laboratories, Academic Research Institutes, Hospital-based Laboratories, and Others. Based on Allergen, the market is segmented into Inhaled, Drug, Food, and Others. Based on Test Type, the market is segmented into In Vivo and In Vitro. Based on Product & Services, the market is segmented into Consumables, Instruments, and Services. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Hitachi chemical Diagnostic Inc., Hycor Biomedical Inc., Lincoln Diagnostics Inc., Omega Diagnostic Llc, Siemens Healthcare Diagnostics, Inc., Thermo Fisher Scientific Inc., Neogen Corporation, Eurofins Scientific Group, and ACON Laboratories, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End-user

• Diagnostic Laboratories
• Academic Research Institutes
• Hospital-based Laboratories
• Others

By Allergen

• Inhaled
• Drug
• Food
• Others

By Test Type

• In Vivo
• In Vitro

By Product & Services

• Consumables
• Instruments
• Services

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Danaher Corporation
• Hitachi chemical Diagnostic Inc.
• Hycor Biomedical Inc.
• Lincoln Diagnostics Inc.
• Omega Diagnostic Llc
• Siemens Healthcare Diagnostics, Inc.
• Thermo Fisher Scientific Inc.
• Neogen Corporation
• Eurofins Scientific Group
• ACON Laboratories, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free